Dipeptidyl peptidase-4 inhibitor compared with sulfonylurea in combination with metformin: cardiovascular and renal outcomes in a propensity-matched cohort study

BACKGROUND: To determine the impact of dipeptidyl peptidase-4 inhibitor (DPP4i) on the risk of major cardiocerebrovascular and renal outcomes compared with sulfonylurea (SU) combined with metformin in patients with type 2 diabetes from a population-based cohort. METHODS: From a nationwide cohort in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cardiovasc Diabetol
Main Authors: Kim, Kyoung Jin, Choi, Jimi, Lee, Juneyoung, Bae, Jae Hyun, An, Jee Hyun, Kim, Hee Young, Yoo, Hye Jin, Seo, Ji A., Kim, Nan Hee, Choi, Kyung Mook, Baik, Sei Hyun, Kim, Sin Gon, Kim, Nam Hoon
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6410523/
https://ncbi.nlm.nih.gov/pubmed/30857540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-019-0835-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados